Catalyst Calendar

Mon, Sep 14, 2026

1 updates

8:30 AM

Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement

Under the terms of the Amendment, all disputed issues are resolved SAN DIEGO and NERVIANO, Italy, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ: CRDF) ("Cardiff") and Nerviano Medical Sciences S.r.l. ("NMS") today announced that they have reached a settlement and amended their

cardiffoncology.com

Wed, Sep 2, 2026

1 updates

CRDF

7:00 AM

Cardiff Oncology to Participate in September 2026 Conferences

SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that Mani Mohindru, Ph.D. will participate in two upcoming conferences.

cardiffoncology.com